EGFR and breast cancer: Even though it is still necessary to further investigate if EGFR signaling activation observed in MCF10A/CD90+ cell model is really caused by CD90 expression and not due to upstream signal or other receptors cross-talk, the possible relationship between high levels of CD90 and activation of the EGFR pathway is a promising finding in breast cancer.